| Connections between metabolism and epigenetics in cancers C Thakur, F Chen Seminars in cancer biology 57, 52-58, 2019 | 158 | 2019 |
| Mdig de-represses H19 large intergenic non-coding RNA (lincRNA) by down-regulating H3K9me3 and heterochromatin B Chen, M Yu, Q Chang, Y Lu, C Thakur, D Ma, Z Yi, F Chen Oncotarget 4 (9), 1427, 2013 | 100 | 2013 |
| Combinatorial treatment of mammospheres with trastuzumab and salinomycin efficiently targets HER2‐positive cancer cells and cancer stem cells PS Oak, F Kopp, C Thakur, JW Ellwart, UR Rapp, A Ullrich, E Wagner, ... International Journal of Cancer 131 (12), 2808-2819, 2012 | 97 | 2012 |
| Gefitinib resistance resulted from STAT3-mediated Akt activation in lung cancer cells K Wu, Q Chang, Y Lu, P Qiu, B Chen, C Thakur, J Sun, L Li, A Kowluru, ... Oncotarget 4 (12), 2430, 2013 | 74 | 2013 |
| Carcinogenic metalloid arsenic induces expression of mdig oncogene through JNK and STAT3 activation J Sun, M Yu, Y Lu, C Thakur, B Chen, P Qiu, H Zhao, F Chen Cancer letters 346 (2), 257-263, 2014 | 63 | 2014 |
| Arsenic-induced sub-lethal stress reprograms human bronchial epithelial cells to CD61 cancer stem cells Q Chang, B Chen, C Thakur, Y Lu, F Chen Oncotarget 5 (5), 1290, 2014 | 54 | 2014 |
| Oncoprotein mdig contributes to silica-induced pulmonary fibrosis by altering balance between Th17 and Treg T cells C Thakur, M Wolfarth, J Sun, Y Zhang, Y Lu, L Battelli, DW Porter, F Chen Oncotarget 6 (6), 3722, 2015 | 53 | 2015 |
| Nrf2 and HIF1α converge to arsenic-induced metabolic reprogramming and the formation of the cancer stem-like cells Z Bi, Q Zhang, Y Fu, P Wadgaonkar, W Zhang, B Almutairy, L Xu, Y Qiu, ... Theranostics 10 (9), 4134, 2020 | 51 | 2020 |
| Paradoxical roles of mineral dust induced gene on cell proliferation and migration/invasion M Yu, J Sun, C Thakur, B Chen, Y Lu, H Zhao, F Chen PLoS One 9 (2), e87998, 2014 | 46 | 2014 |
| Reactive oxygen species contribute to arsenic-induced EZH2 phosphorylation in human bronchial epithelial cells and lung cancer cells L Li, P Qiu, B Chen, Y Lu, K Wu, C Thakur, Q Chang, J Sun, F Chen Toxicology and applied pharmacology 276 (3), 165-170, 2014 | 45 | 2014 |
| Increased expression of mdig predicts poorer survival of the breast cancer patients C Thakur, Y Lu, J Sun, M Yu, B Chen, F Chen Gene 535 (2), 218-224, 2014 | 42 | 2014 |
| Metabolic and epigenetic reprogramming in the arsenic-induced cancer stem cells L Li, Z Bi, P Wadgaonkar, Y Lu, Q Zhang, Y Fu, C Thakur, L Wang, F Chen Seminars in cancer biology 57, 10-18, 2019 | 40 | 2019 |
| Loss of mdig expression enhances DNA and histone methylation and metastasis of aggressive breast cancer C Thakur, B Chen, L Li, Q Zhang, ZQ Yang, F Chen Signal transduction and targeted therapy 3 (1), 25, 2018 | 40 | 2018 |
| E-cadherin controls bronchiolar progenitor cells and onset of preneoplastic lesions in mice F Ceteci, S Ceteci, E Zanucco, C Thakur, M Becker, N El-Nikhely, L Fink, ... Neoplasia 14 (12), 1164-IN31, 2012 | 35 | 2012 |
| Mdig promotes oncogenic gene expression through antagonizing repressive histone methylation markers Q Zhang, C Thakur, Y Fu, Z Bi, P Wadgaonkar, L Xu, Z Liu, W Liu, J Wang, ... Theranostics 10 (2), 602, 2020 | 31 | 2020 |
| Current understanding of mdig/MINA in human cancers C Thakur, F Chen Genes & Cancer 6 (7-8), 288, 2015 | 28 | 2015 |
| Epigenetics and environment in breast cancer: New paradigms for anti-cancer therapies C Thakur, Y Qiu, Y Fu, Z Bi, W Zhang, H Ji, F Chen Frontiers in Oncology 12, 971288, 2022 | 25 | 2022 |
| New discoveries of mdig in the epigenetic regulation of cancers Q Zhang, C Thakur, J Shi, J Sun, Y Fu, P Stemmer, F Chen Seminars in cancer biology 57, 27-35, 2019 | 25 | 2019 |
| Proteomic Characterization of the World Trade Center dust-activated mdig and c-myc signaling circuit linked to multiple myeloma K Wu, L Li, C Thakur, Y Lu, X Zhang, Z Yi, F Chen Scientific reports 6 (1), 36305, 2016 | 23 | 2016 |
| Sequential salinomycin treatment results in resistance formation through clonal selection of epithelial-like tumor cells F Kopp, A Hermawan, PS Oak, VK Ulaganathan, A Herrmann, N Elnikhely, ... Translational oncology 7 (6), 702-711, 2014 | 21 | 2014 |
